| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |